June 2023
Lizet Sanchez Valdes > Other Awards
1-Epidemiological evaluation of risks, equity and results of vaccination in the sustainable control of COVI D-19 in Cuba.
2-Clinical and seroepidemiological surveillance of dengue in Havana. 1997-2019.
3-Repositioning of the Cuban humanized monoclonal antibody Nimotuzumab in the treatment of patients with COVID-19,
August 2023
Lizet Sanchez Valdes > Other Awards
Social impact of scientific modeling in the multidisciplinary confrontation of COVID-19 in Cuba
July 2021
Lizet Sanchez Valdes > Other Awards
The acknowledgement is sponsored by the Kovalevskaya Foundation and the Faculty of Mathematics and Computing of the University of Havana, and its purpose is to encourage women from developing countries to participate actively in the scientific and technological life of their nations.
Full Member
Mrs. Lizet Sanchez Valdes
Membership since:
2024
Field of activity:
Degrees:
2006
Doctorate
Medical and Health Sciences incl Neurosciences
2023
Doctorate
Mathematical sciences
Publications resulting from Research
Ortiz Carrodeguas, R. A., et al. (2024). "Safety and effectiveness of CIMAvax-EGF administered in community polyclinics." Frontiers in Oncology 13: 1287902.
De Witte, D., et al. (2023). "A multivariate spatio-temporal model for the incidence of imported COVID-19 cases and COVID-19 deaths in Cuba." Spatial and Spatio-temporal Epidemiology 45: 100588.
Sánchez, Y., et al. (2023). "Nimotuzumab Concurrent with Gemcitabine as First‐Line Treatment of Locally Advanced or Metastatic Pancreatic Adenocarcinoma." BioMed Research International 2023(1): 1496072.
Diaz, H., et al. (2022). "Nimotuzumab Increases the Recovery Rate of Severe and Critical COVID-19 Patients: Evaluation in the Real-World Scenario." Frontiers in Public Health 10: 948520.
Alonso A et al. (2022). "Identifying individual predictive factors for treatment efficacy". Biometrics. 78(1):35-45.
Más-Bermejo, P. I., et al. (2022). "Cuban Abdala vaccine: Effectiveness in preventing severe disease and death from COVID-19 in Havana, Cuba; A cohort study." The Lancet Regional Health–Americas 18:100422
Caballero, A., et al. (2020). "Treatment of COVID‐19 patients with the anti‐CD6 antibody itolizumab." Clinical & Translational Immunology 9(11): e1218.
Lorenzo-Luaces, P., et al. (2020). "Identifying predictive biomarkers of CIMAvaxEGF success in non–small cell lung cancer patients." BMC cancer 20: 1-8.
Sanchez, L., et al. (2018). Differential effects of two therapeutic cancer vaccines on short-and long-term survival populations among patients with advanced lung cancer. Seminars in Oncology, 45(1-2):52-57.
Sebrango-Rodríguez, C. R., et al. (2017). "Real-time parameter estimation of Zika outbreaks using model averaging." Epidemiology & Infection 145(11): 2313-2323.
COMPUMAT
2025
Havana
BioHabana
2025
Havana
Moving from COVID-19 Mathematical Models to Vaccine Desing: Theory, Practice and Experiences
2025
Mexico